A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)

Trial Profile

A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)

Phase of Trial: Phase I

Latest Information Update: 26 Feb 2018

At a glance

  • Drugs RNS 60 (Primary) ; RNS 60 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 05 Jan 2018 Status changed from active, no longer recruiting to completed.
    • 06 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Mar 2018.
    • 06 Apr 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top